Intensive blood pressure lowering and the risk of new-onset diabetes in patients with hypertension: a post-hoc analysis of the STEP randomized trial

R Yang, Y Zhu, M Xu, Y Tao, W Cong… - European Journal of …, 2023 - academic.oup.com
Aims The strategy of blood pressure intervention in the elderly hypertensive patients (STEP)
trial reported the cardiovascular benefit of intensive systolic blood pressure (SBP) control in …

The Influence of baseline glycemic status on the effects of intensive blood pressure lowering: Results from the STEP randomized trial

R Yang, Y Wang, A Tong, J Yu, D Zhao, J Cai - European Journal of Internal …, 2023 - Elsevier
Background Intensive systolic blood pressure (SBP) lowering showed cardiovascular
benefits in the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients …

Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: a secondary analysis of the SPRINT trial

A Attar, M Sayadi, M Jannati - European journal of …, 2019 - journals.sagepub.com
Background It is not clear whether risk stratification can help choose the most favourable
systolic blood pressure target for primary prevention of cardiovascular events. Design A …

Intensive blood pressure control and diabetes mellitus incidence for patients with impaired fasting glucose: a secondary analysis of SPRINT

B Lin, X Liu, S Yao, Z Pan - International Journal of …, 2023 - Wiley Online Library
Background. Previous studies indicated that intensive blood pressure (BP) control (systolic
BP< 120 mm· Hg) compared with standard BP control (< 140 mm· Hg) was associated with …

Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD‐BP randomized trials

R Yang, J Bai, Z Fang, Y Wang, Y Feng… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To determine whether intensive systolic blood pressure (SBP) lowering can benefit
hypertensive patients with diabetes. Materials and Methods We performed a pooled analysis …

Intensive blood pressure lowering in patients with and patients without type 2 diabetes: a pooled analysis from two randomized trials

TF Brouwer, JT Vehmeijer, DN Kalkman… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE The Action to Control Cardiovascular Risk in Diabetes Blood Pressure
(ACCORD-BP) study did not find a significant beneficial effect of intensive systolic blood …

J-shaped relationship between cardiovascular risk and efficacy of intensive blood pressure reduction: A post-hoc analysis of the SPRINT trial

A Attar, F Nouri, R Borazjani, M Sayadi - Plos one, 2020 - journals.plos.org
Background In the 2017 ACC/AHA hypertension guidelines, a 10-year risk of more than 10%
is considered for initiation of intensive blood pressure reduction. The current study aimed to …

Cardiovascular outcomes in patients with diabetes when initiating blood pressure lowering at baseline SBP between 130 and 140 mm Hg: A meta‐analysis

S Wang, NM Djama, Y Lai, H Li, W Liao… - The Journal of …, 2019 - Wiley Online Library
The efficacy and safety of blood pressure (BP) lowering initiated at baseline systolic BP
(SBP) of 130‐140 mm Hg in patients with diabetes remain controversial. The authors aimed …

Intensive blood pressure lowering reduces adverse cardiovascular outcomes among patients with high‐normal glucose: an analysis from the Systolic Blood Pressure …

Y Gong, SM Smith, EM Handberg… - The Journal of …, 2018 - Wiley Online Library
The objective of this analysis is to determine the effect of intensive (< 120 mm Hg) versus
standard (< 140 mm Hg) systolic blood pressure (SBP) targets on cardiovascular (CV) …

Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering: Results From the STEP Randomized Trial

R Yang, R Huang, L Zhang, D Li, J Luo, J Cai - Hypertension, 2023 - Am Heart Assoc
BACKGROUND: The STEP (Strategy of Blood Pressure Intervention in the Elderly
Hypertensive Patients) trial demonstrated that intensive systolic blood pressure (SBP) …